Gyre Therapeutics
GYRE
23 hedge funds and large institutions have $5.86M invested in Gyre Therapeutics in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 6 closing their positions.
136% more capital invested
Capital invested by funds: $2.48M → $5.86M (+$3.38M)
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
35% more funds holding
Funds holding: 17 → 23 (+6)
0.46% more ownership
Funds ownership: 3.49% → 3.94% (+0.46%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $11K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$1.69M |
| 2 |
Renaissance Technologies
New York
|
+$1.31M |
| 3 |
BlackRock
New York
|
+$785K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$383K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$156K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
-$156K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$80K |
| 3 |
FPF
FNY Partners Fund
New York
|
-$26K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$2.4K |
GYRE Hedge Fund Activity: Q2 2017 in Review
23 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q2 2017, worth a combined $5.86M — up 136% from $2.48M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new GYRE positions and 6 closed out — a net gain of 6 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $1.69M. The largest seller was Simplex Trading, exiting entirely with an estimated $156K sold.
- 23 institutional investors held Gyre Therapeutics (GYRE) as of Q2 2017, up from 17 in Q1 2017.
- Funds reported $5.86M of Gyre Therapeutics stock for Q2 2017, up 136% quarter-over-quarter.
- 12 funds opened new Gyre Therapeutics positions in Q2 2017 and 6 closed out, a net change of +6 holders.
- The largest Gyre Therapeutics buyer in Q2 2017 was Sio Capital Management, an estimated $1.69M added.
- The largest Gyre Therapeutics seller in Q2 2017 was Simplex Trading, an estimated $156K sold.
Based on aggregated 13F filings for Q2 2017.